Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia
There are reports of de novo development or exacerbation of obsessive-compulsive symptoms in patients with schizophrenia treated with atypical antipsychotics, although this is widely debated. We report one such case where a patient with a primary diagnosis of schizophrenia, treated with olanzapine,...
Gespeichert in:
| Veröffentlicht in: | Indian journal of pharmacology 2012-09, Vol.44 (5), p.649-650 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 650 |
|---|---|
| container_issue | 5 |
| container_start_page | 649 |
| container_title | Indian journal of pharmacology |
| container_volume | 44 |
| creator | Kulkarni, Gajanan Narayanaswamy, Janardhanan C Math, Suresh Bada |
| description | There are reports of de novo development or exacerbation of obsessive-compulsive symptoms in patients with schizophrenia treated with atypical antipsychotics, although this is widely debated. We report one such case where a patient with a primary diagnosis of schizophrenia, treated with olanzapine, developed de novo obsessive-compulsive disorder, with convincing evidence for its causality due to the drug. |
| doi_str_mv | 10.4103/0253-7613.100406 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3480803</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A302182644</galeid><sourcerecordid>A302182644</sourcerecordid><originalsourceid>FETCH-LOGICAL-c529t-bd0653407767725f59edc55d865ffb3cc5950c1821653e0e63968701de644c5e3</originalsourceid><addsrcrecordid>eNptUk2P0zAQtRCILQt3TigS55RxHDvJBWm14ktaaS8gcbNce9J6ldjBTorYX8-ULoWVKh_s8bz3_DwzjL3msK45iHdQSVE2ios1B6hBPWEr3nVtKRrJn7LVKX3BXuR8BxTXnXrOLirBeVWLasW-3w4m3JvJByx8cItFVzgsQ9zHIm4y5uz3WNg4Tsvw5-h8jslhInRhisnMHsNc_PTzrsh25-_jtEsYvHnJnvVmyPjqYb9k3z5--Hr9uby5_fTl-uqmtLLq5nLjQElRQ9OopqlkLzt0VkrXKtn3G2Gt7CRY3lacYAioRKfaBrhDVddWorhk74-607IZiUtukhn0lPxo0i8djdePM8Hv9DbutahbaEGQwNsHgRR_LJhnfReXFMizphJ30Ary9w-1NQNqH_pIYnb02eorARUZJD-EKs-gthiQXo4Be0_Xj_DrM3haDkdvzxLgSLAp5pywP32Ugz6MhD70XB96ro8jQZQ3_xfoRPg7A-I3d9ev2A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1039083534</pqid></control><display><type>article</type><title>Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia</title><source>MEDLINE</source><source>Full-Text Journals in Chemistry (Open access)</source><source>PubMed Central</source><source>EZB Electronic Journals Library</source><source>PubMed Central Open Access</source><creator>Kulkarni, Gajanan ; Narayanaswamy, Janardhanan C ; Math, Suresh Bada</creator><creatorcontrib>Kulkarni, Gajanan ; Narayanaswamy, Janardhanan C ; Math, Suresh Bada</creatorcontrib><description>There are reports of de novo development or exacerbation of obsessive-compulsive symptoms in patients with schizophrenia treated with atypical antipsychotics, although this is widely debated. We report one such case where a patient with a primary diagnosis of schizophrenia, treated with olanzapine, developed de novo obsessive-compulsive disorder, with convincing evidence for its causality due to the drug.</description><identifier>ISSN: 0253-7613</identifier><identifier>EISSN: 1998-3751</identifier><identifier>DOI: 10.4103/0253-7613.100406</identifier><identifier>PMID: 23112432</identifier><language>eng</language><publisher>India: Medknow Publications and Media Pvt. Ltd</publisher><subject>Adult ; Antipsychotic Agents - adverse effects ; Benzodiazepines - adverse effects ; Care and treatment ; Development and progression ; Drug Watch ; Female ; Health aspects ; Humans ; Neuroses ; Obsessive compulsive disorder ; Obsessive-Compulsive Disorder - chemically induced ; Obsessive-Compulsive Disorder - diagnosis ; Olanzapine ; Physiological aspects ; Psychopharmacology ; Psychotropic drugs ; Schizophrenia ; Schizophrenia - drug therapy ; Schizophrenics ; Side effects</subject><ispartof>Indian journal of pharmacology, 2012-09, Vol.44 (5), p.649-650</ispartof><rights>COPYRIGHT 2012 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications & Media Pvt Ltd Sep 2012</rights><rights>Copyright: © Indian Journal of Pharmacology 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c529t-bd0653407767725f59edc55d865ffb3cc5950c1821653e0e63968701de644c5e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480803/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480803/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23112432$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kulkarni, Gajanan</creatorcontrib><creatorcontrib>Narayanaswamy, Janardhanan C</creatorcontrib><creatorcontrib>Math, Suresh Bada</creatorcontrib><title>Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia</title><title>Indian journal of pharmacology</title><addtitle>Indian J Pharmacol</addtitle><description>There are reports of de novo development or exacerbation of obsessive-compulsive symptoms in patients with schizophrenia treated with atypical antipsychotics, although this is widely debated. We report one such case where a patient with a primary diagnosis of schizophrenia, treated with olanzapine, developed de novo obsessive-compulsive disorder, with convincing evidence for its causality due to the drug.</description><subject>Adult</subject><subject>Antipsychotic Agents - adverse effects</subject><subject>Benzodiazepines - adverse effects</subject><subject>Care and treatment</subject><subject>Development and progression</subject><subject>Drug Watch</subject><subject>Female</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Neuroses</subject><subject>Obsessive compulsive disorder</subject><subject>Obsessive-Compulsive Disorder - chemically induced</subject><subject>Obsessive-Compulsive Disorder - diagnosis</subject><subject>Olanzapine</subject><subject>Physiological aspects</subject><subject>Psychopharmacology</subject><subject>Psychotropic drugs</subject><subject>Schizophrenia</subject><subject>Schizophrenia - drug therapy</subject><subject>Schizophrenics</subject><subject>Side effects</subject><issn>0253-7613</issn><issn>1998-3751</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptUk2P0zAQtRCILQt3TigS55RxHDvJBWm14ktaaS8gcbNce9J6ldjBTorYX8-ULoWVKh_s8bz3_DwzjL3msK45iHdQSVE2ios1B6hBPWEr3nVtKRrJn7LVKX3BXuR8BxTXnXrOLirBeVWLasW-3w4m3JvJByx8cItFVzgsQ9zHIm4y5uz3WNg4Tsvw5-h8jslhInRhisnMHsNc_PTzrsh25-_jtEsYvHnJnvVmyPjqYb9k3z5--Hr9uby5_fTl-uqmtLLq5nLjQElRQ9OopqlkLzt0VkrXKtn3G2Gt7CRY3lacYAioRKfaBrhDVddWorhk74-607IZiUtukhn0lPxo0i8djdePM8Hv9DbutahbaEGQwNsHgRR_LJhnfReXFMizphJ30Ary9w-1NQNqH_pIYnb02eorARUZJD-EKs-gthiQXo4Be0_Xj_DrM3haDkdvzxLgSLAp5pywP32Ugz6MhD70XB96ro8jQZQ3_xfoRPg7A-I3d9ev2A</recordid><startdate>20120901</startdate><enddate>20120901</enddate><creator>Kulkarni, Gajanan</creator><creator>Narayanaswamy, Janardhanan C</creator><creator>Math, Suresh Bada</creator><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications & Media Pvt. Ltd</general><general>Medknow Publications & Media Pvt Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>20120901</creationdate><title>Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia</title><author>Kulkarni, Gajanan ; Narayanaswamy, Janardhanan C ; Math, Suresh Bada</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c529t-bd0653407767725f59edc55d865ffb3cc5950c1821653e0e63968701de644c5e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Antipsychotic Agents - adverse effects</topic><topic>Benzodiazepines - adverse effects</topic><topic>Care and treatment</topic><topic>Development and progression</topic><topic>Drug Watch</topic><topic>Female</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Neuroses</topic><topic>Obsessive compulsive disorder</topic><topic>Obsessive-Compulsive Disorder - chemically induced</topic><topic>Obsessive-Compulsive Disorder - diagnosis</topic><topic>Olanzapine</topic><topic>Physiological aspects</topic><topic>Psychopharmacology</topic><topic>Psychotropic drugs</topic><topic>Schizophrenia</topic><topic>Schizophrenia - drug therapy</topic><topic>Schizophrenics</topic><topic>Side effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kulkarni, Gajanan</creatorcontrib><creatorcontrib>Narayanaswamy, Janardhanan C</creatorcontrib><creatorcontrib>Math, Suresh Bada</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Indian journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kulkarni, Gajanan</au><au>Narayanaswamy, Janardhanan C</au><au>Math, Suresh Bada</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia</atitle><jtitle>Indian journal of pharmacology</jtitle><addtitle>Indian J Pharmacol</addtitle><date>2012-09-01</date><risdate>2012</risdate><volume>44</volume><issue>5</issue><spage>649</spage><epage>650</epage><pages>649-650</pages><issn>0253-7613</issn><eissn>1998-3751</eissn><abstract>There are reports of de novo development or exacerbation of obsessive-compulsive symptoms in patients with schizophrenia treated with atypical antipsychotics, although this is widely debated. We report one such case where a patient with a primary diagnosis of schizophrenia, treated with olanzapine, developed de novo obsessive-compulsive disorder, with convincing evidence for its causality due to the drug.</abstract><cop>India</cop><pub>Medknow Publications and Media Pvt. Ltd</pub><pmid>23112432</pmid><doi>10.4103/0253-7613.100406</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0253-7613 |
| ispartof | Indian journal of pharmacology, 2012-09, Vol.44 (5), p.649-650 |
| issn | 0253-7613 1998-3751 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3480803 |
| source | MEDLINE; Full-Text Journals in Chemistry (Open access); PubMed Central; EZB Electronic Journals Library; PubMed Central Open Access |
| subjects | Adult Antipsychotic Agents - adverse effects Benzodiazepines - adverse effects Care and treatment Development and progression Drug Watch Female Health aspects Humans Neuroses Obsessive compulsive disorder Obsessive-Compulsive Disorder - chemically induced Obsessive-Compulsive Disorder - diagnosis Olanzapine Physiological aspects Psychopharmacology Psychotropic drugs Schizophrenia Schizophrenia - drug therapy Schizophrenics Side effects |
| title | Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T18%3A35%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Olanzapine%20induced%20de-novo%20obsessive%20compulsive%20disorder%20in%20a%20patient%20with%20schizophrenia&rft.jtitle=Indian%20journal%20of%20pharmacology&rft.au=Kulkarni,%20Gajanan&rft.date=2012-09-01&rft.volume=44&rft.issue=5&rft.spage=649&rft.epage=650&rft.pages=649-650&rft.issn=0253-7613&rft.eissn=1998-3751&rft_id=info:doi/10.4103/0253-7613.100406&rft_dat=%3Cgale_pubme%3EA302182644%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1039083534&rft_id=info:pmid/23112432&rft_galeid=A302182644&rfr_iscdi=true |